BIOCHEMISTRY ANALYZERS MARKET ANALYSIS
Key market players are focusing on improvement in patient care by broadening access to high-quality test results. Thus global biochemistry analyzers market growth can be driven by an increase in product launches by the key market players over the forecast period. For instance, in November 2022, Roche, healthcare company, nnounced the cobas 5800 System, a compact, fully-automated molecular laboratory instrument that offers a flexible, PCR testing solution that aids clinicians in the diagnosis of infectious diseases. The cobas 5800 is designed to provide optimized workflow efficiencies, simplicity, and timely results that can benefit labs of all sizes.
Global Biochemistry Analyzers Market: Key Developments
In March 2020, Abbott Diagnostics, medical devices and healthcare company, announced that the U.S. Food and Drug Administration had issued emergency use authorization for the m2000 RealTime system for the novel coronavirus (COVID-19). This molecular platform uses PCR technology for obtaining a broad menu of tests and it has been used in laboratories around the world.
In November 2022, Siemens Healthineers, a medical device company, and Atrium Health, a healthcare company, announced a multi-year value partnership agreement. This strategic agreement focused on driving access to care in Atrium Health's service region across the southeastern U.S. Atrium Health purchased medical devices and equipment for enhancing economic mobility and improvement of health equity.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
